Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Quest Diagnostics (NYSE: DGX) Delayed: 193.62 -1.38 (0.71%)
Previous Close $195.00    52 Week High $86.85 
Open $194.13    52 Week Low $59.66 
Day High $195.16    P/E 36.46 
Day Low $192.90    EPS $5.31 
Volume 581,540